These wide- and narrow-moat stocks have suffered losses lately and are now trading in 4- and 5-star range.
We think the market is over-reacting to new drug pricing proposals, creating a buying opportunity.
Retailers posted solid numbers this earnings season, but we think their stocks are, in general, overbought--with some exceptions.
As second-quarter earnings season winds down, we take a look at our analysts’ valuation changes across sectors.
A regulatory crackdown has left some big names at cheap prices.
These stocks struggled in the second quarter but are also trading at bargain prices.
As the oil slide dents the energy stock rally, only a few bargains have emerged.
Energy and tech stocks lead as the U.S. market rally continued
These funds had the largest holdings of the drugmaker's stock before it soared.
These stocks offer solid dividends and low ESG risk.
Three sectors saw the most fair value increases after the first-quarter earnings season.
There are other ways to play streaming media than Netflix and Disney
Colonial ransomware attack highlights the demand tailwind.